Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06975241
PHASE4

Observing Metabolism of EPA With Consideration of Genetics And Sex

Sponsor: University of Toronto

View on ClinicalTrials.gov

Summary

The goal of this clinical study is to learn how fast EPA is converted to other molecules, including DHA, with consideration of biological sex and genetics in healthy humans. The main questions it aims to answer are: * How fast is EPA converted to DHA in blood, and is the conversion rate affected by sex and a specific genotype we previously identified? * How do sex and the specific genotypes affect blood DHA levels and other products of DHA in response to dietary EPA? * How fast does dietary EPA replace blood EPA and other omega-3 fatty acids, and is the rate affected by sex and genotype? Participants will be asked to take EPA supplements for 12 weeks and provide a series of venous blood samples over the study duration.

Official title: Determining Contribution of Sex and Genetics to DHA Synthesis Rates Over 12 Weeks of EPA Supplementation in Healthy Individuals

Key Details

Gender

All

Age Range

18 Years - 35 Years

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2025-07-29

Completion Date

2026-09

Last Updated

2026-02-27

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

EPA 2.4g/day

EPA from fish oil will be supplemented to an equal number of males and females for 12 weeks.

Locations (1)

Clinical Nutrition and Risk Factor Modification Centre

Toronto, Ontario, Canada